Interleukin-1β weakens paclitaxel sensitivity through regulating autophagy in the non-small cell lung cancer cell line A549

Non-small cell lung cancer (NSCLC) poses a threat to human health and paclitaxel chemotherapy has been approved for the treatment of this type of cancer. However, resistance to treatment severely compromises the survival rate and prognosis of patients with NSCLC. The aim of the present study was to...

Descripción completa

Detalles Bibliográficos
Autores principales: Lian, Juanwen, Hua, Tao, Xu, Jialing, Ding, Jie, Liu, Zejie, Fan, Yu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885084/
https://www.ncbi.nlm.nih.gov/pubmed/33717236
http://dx.doi.org/10.3892/etm.2021.9724

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7885084/
https://www.ncbi.nlm.nih.gov/pubmed/33717236
http://dx.doi.org/10.3892/etm.2021.9724

Ejemplares similares